Usa covid-19 Government infection Coronavirus Usa

AstraZeneca begins efforts to identify antibodies against Covid-19

Reading now: 356
www.pharmaceutical-technology.com

AstraZeneca has begun research efforts focused on the identification and development of antibody therapies against Covid-19 coronavirus infection.

The company will use its in-house capabilities and form alliances to discover monoclonal antibodies that could detect, attach to and neutralise the SARS-CoV-2.

Synthesised in a laboratory, monoclonal antibodies work similarly to natural antibodies. They neutralise the virus and can act as a preventative, as well as a treatment.

Internally, biopharmaceutical experts at AstraZeneca are leveraging its antibody discovery technology, which previously helped in identifying potential antibodies for influenza-A.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA